nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—SLCO1B1—Sulfasalazine—Crohn's disease	0.445	0.482	CbGbCtD
Fexofenadine—SLCO1A2—Prednisone—Crohn's disease	0.377	0.408	CbGbCtD
Fexofenadine—ABCB1—Prednisone—Crohn's disease	0.102	0.11	CbGbCtD
Fexofenadine—Upset stomach—Mesalazine—Crohn's disease	0.00305	0.0412	CcSEcCtD
Fexofenadine—Rhinorrhoea—Mesalazine—Crohn's disease	0.00246	0.0333	CcSEcCtD
Fexofenadine—Dysmenorrhoea—Mesalazine—Crohn's disease	0.0022	0.0297	CcSEcCtD
Fexofenadine—Dry eye—Mesalazine—Crohn's disease	0.00184	0.0249	CcSEcCtD
Fexofenadine—Ear pain—Mesalazine—Crohn's disease	0.0017	0.023	CcSEcCtD
Fexofenadine—Increased appetite—Mesalazine—Crohn's disease	0.00154	0.0208	CcSEcCtD
Fexofenadine—Atrial fibrillation—Mesalazine—Crohn's disease	0.00153	0.0207	CcSEcCtD
Fexofenadine—Thirst—Mesalazine—Crohn's disease	0.00152	0.0206	CcSEcCtD
Fexofenadine—Abdominal discomfort—Azathioprine—Crohn's disease	0.00132	0.0178	CcSEcCtD
Fexofenadine—Nasopharyngitis—Mesalazine—Crohn's disease	0.0013	0.0175	CcSEcCtD
Fexofenadine—Abdominal discomfort—Mesalazine—Crohn's disease	0.0012	0.0162	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.0012	0.0162	CcSEcCtD
Fexofenadine—Viral infection—Prednisone—Crohn's disease	0.00117	0.0158	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00116	0.0157	CcSEcCtD
Fexofenadine—Pollakiuria—Mesalazine—Crohn's disease	0.00116	0.0156	CcSEcCtD
Fexofenadine—Epistaxis—Mesalazine—Crohn's disease	0.00105	0.0142	CcSEcCtD
Fexofenadine—Sinusitis—Mesalazine—Crohn's disease	0.00105	0.0142	CcSEcCtD
Fexofenadine—Body temperature increased—Mercaptopurine—Crohn's disease	0.00104	0.014	CcSEcCtD
Fexofenadine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000967	0.0131	CcSEcCtD
Fexofenadine—Diarrhoea—Mercaptopurine—Crohn's disease	0.000898	0.0121	CcSEcCtD
Fexofenadine—Flatulence—Mesalazine—Crohn's disease	0.00086	0.0116	CcSEcCtD
Fexofenadine—Tension—Mesalazine—Crohn's disease	0.000857	0.0116	CcSEcCtD
Fexofenadine—Nervousness—Mesalazine—Crohn's disease	0.000848	0.0115	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Prednisone—Crohn's disease	0.000846	0.0114	CcSEcCtD
Fexofenadine—Back pain—Mesalazine—Crohn's disease	0.000844	0.0114	CcSEcCtD
Fexofenadine—Vomiting—Mercaptopurine—Crohn's disease	0.000835	0.0113	CcSEcCtD
Fexofenadine—Injury—Prednisone—Crohn's disease	0.000834	0.0113	CcSEcCtD
Fexofenadine—Rash—Mercaptopurine—Crohn's disease	0.000828	0.0112	CcSEcCtD
Fexofenadine—Dermatitis—Mercaptopurine—Crohn's disease	0.000827	0.0112	CcSEcCtD
Fexofenadine—Vision blurred—Mesalazine—Crohn's disease	0.000823	0.0111	CcSEcCtD
Fexofenadine—Increased appetite—Prednisone—Crohn's disease	0.000816	0.011	CcSEcCtD
Fexofenadine—Myalgia—Azathioprine—Crohn's disease	0.000816	0.011	CcSEcCtD
Fexofenadine—Angioedema—Mesalazine—Crohn's disease	0.000798	0.0108	CcSEcCtD
Fexofenadine—Nausea—Mercaptopurine—Crohn's disease	0.00078	0.0105	CcSEcCtD
Fexofenadine—Infection—Azathioprine—Crohn's disease	0.000777	0.0105	CcSEcCtD
Fexofenadine—Palpitations—Mesalazine—Crohn's disease	0.000771	0.0104	CcSEcCtD
Fexofenadine—Cough—Mesalazine—Crohn's disease	0.000762	0.0103	CcSEcCtD
Fexofenadine—Psychotic disorder—Prednisone—Crohn's disease	0.000749	0.0101	CcSEcCtD
Fexofenadine—Myalgia—Mesalazine—Crohn's disease	0.000743	0.01	CcSEcCtD
Fexofenadine—Dry mouth—Mesalazine—Crohn's disease	0.000727	0.00982	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000713	0.00963	CcSEcCtD
Fexofenadine—Anaphylactic shock—Mesalazine—Crohn's disease	0.000712	0.00963	CcSEcCtD
Fexofenadine—Infection—Mesalazine—Crohn's disease	0.000708	0.00956	CcSEcCtD
Fexofenadine—Tachycardia—Mesalazine—Crohn's disease	0.000695	0.0094	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000649	0.00877	CcSEcCtD
Fexofenadine—Insomnia—Mesalazine—Crohn's disease	0.000644	0.00871	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00064	0.00864	CcSEcCtD
Fexofenadine—Dyspnoea—Mesalazine—Crohn's disease	0.000635	0.00858	CcSEcCtD
Fexofenadine—Somnolence—Mesalazine—Crohn's disease	0.000633	0.00856	CcSEcCtD
Fexofenadine—Dyspepsia—Mesalazine—Crohn's disease	0.000627	0.00847	CcSEcCtD
Fexofenadine—Body temperature increased—Azathioprine—Crohn's disease	0.000618	0.00836	CcSEcCtD
Fexofenadine—Abdominal pain—Azathioprine—Crohn's disease	0.000618	0.00836	CcSEcCtD
Fexofenadine—Fatigue—Mesalazine—Crohn's disease	0.000614	0.0083	CcSEcCtD
Fexofenadine—Pain—Mesalazine—Crohn's disease	0.000609	0.00823	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000583	0.00787	CcSEcCtD
Fexofenadine—Hypersensitivity—Azathioprine—Crohn's disease	0.000576	0.00779	CcSEcCtD
Fexofenadine—Urticaria—Mesalazine—Crohn's disease	0.000566	0.00765	CcSEcCtD
Fexofenadine—Abdominal pain—Mesalazine—Crohn's disease	0.000563	0.00761	CcSEcCtD
Fexofenadine—Body temperature increased—Mesalazine—Crohn's disease	0.000563	0.00761	CcSEcCtD
Fexofenadine—Diarrhoea—Azathioprine—Crohn's disease	0.000535	0.00723	CcSEcCtD
Fexofenadine—Hypersensitivity—Mesalazine—Crohn's disease	0.000525	0.00709	CcSEcCtD
Fexofenadine—Dizziness—Azathioprine—Crohn's disease	0.000517	0.00699	CcSEcCtD
Fexofenadine—Asthenia—Mesalazine—Crohn's disease	0.000511	0.00691	CcSEcCtD
Fexofenadine—Pruritus—Mesalazine—Crohn's disease	0.000504	0.00681	CcSEcCtD
Fexofenadine—Vomiting—Azathioprine—Crohn's disease	0.000497	0.00672	CcSEcCtD
Fexofenadine—Rash—Azathioprine—Crohn's disease	0.000493	0.00666	CcSEcCtD
Fexofenadine—Dermatitis—Azathioprine—Crohn's disease	0.000493	0.00666	CcSEcCtD
Fexofenadine—Flushing—Prednisone—Crohn's disease	0.000492	0.00665	CcSEcCtD
Fexofenadine—Headache—Azathioprine—Crohn's disease	0.00049	0.00662	CcSEcCtD
Fexofenadine—Diarrhoea—Mesalazine—Crohn's disease	0.000487	0.00659	CcSEcCtD
Fexofenadine—Dizziness—Mesalazine—Crohn's disease	0.000471	0.00637	CcSEcCtD
Fexofenadine—Nausea—Azathioprine—Crohn's disease	0.000465	0.00628	CcSEcCtD
Fexofenadine—Vomiting—Mesalazine—Crohn's disease	0.000453	0.00612	CcSEcCtD
Fexofenadine—Rash—Mesalazine—Crohn's disease	0.000449	0.00607	CcSEcCtD
Fexofenadine—Dermatitis—Mesalazine—Crohn's disease	0.000449	0.00606	CcSEcCtD
Fexofenadine—Headache—Mesalazine—Crohn's disease	0.000446	0.00603	CcSEcCtD
Fexofenadine—Vision blurred—Prednisone—Crohn's disease	0.000435	0.00588	CcSEcCtD
Fexofenadine—Agitation—Prednisone—Crohn's disease	0.000424	0.00574	CcSEcCtD
Fexofenadine—Nausea—Mesalazine—Crohn's disease	0.000423	0.00572	CcSEcCtD
Fexofenadine—Angioedema—Prednisone—Crohn's disease	0.000422	0.0057	CcSEcCtD
Fexofenadine—Myalgia—Prednisone—Crohn's disease	0.000393	0.00531	CcSEcCtD
Fexofenadine—Anaphylactic shock—Prednisone—Crohn's disease	0.000377	0.00509	CcSEcCtD
Fexofenadine—Infection—Prednisone—Crohn's disease	0.000374	0.00506	CcSEcCtD
Fexofenadine—Tachycardia—Prednisone—Crohn's disease	0.000368	0.00497	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000343	0.00464	CcSEcCtD
Fexofenadine—Insomnia—Prednisone—Crohn's disease	0.000341	0.00461	CcSEcCtD
Fexofenadine—Dyspepsia—Prednisone—Crohn's disease	0.000332	0.00448	CcSEcCtD
Fexofenadine—Fatigue—Prednisone—Crohn's disease	0.000325	0.00439	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000308	0.00417	CcSEcCtD
Fexofenadine—Urticaria—Prednisone—Crohn's disease	0.000299	0.00405	CcSEcCtD
Fexofenadine—Body temperature increased—Prednisone—Crohn's disease	0.000298	0.00403	CcSEcCtD
Fexofenadine—Abdominal pain—Prednisone—Crohn's disease	0.000298	0.00403	CcSEcCtD
Fexofenadine—Hypersensitivity—Prednisone—Crohn's disease	0.000278	0.00375	CcSEcCtD
Fexofenadine—Asthenia—Prednisone—Crohn's disease	0.00027	0.00365	CcSEcCtD
Fexofenadine—Pruritus—Prednisone—Crohn's disease	0.000267	0.0036	CcSEcCtD
Fexofenadine—Diarrhoea—Prednisone—Crohn's disease	0.000258	0.00349	CcSEcCtD
Fexofenadine—Dizziness—Prednisone—Crohn's disease	0.000249	0.00337	CcSEcCtD
Fexofenadine—Vomiting—Prednisone—Crohn's disease	0.00024	0.00324	CcSEcCtD
Fexofenadine—Rash—Prednisone—Crohn's disease	0.000238	0.00321	CcSEcCtD
Fexofenadine—Dermatitis—Prednisone—Crohn's disease	0.000237	0.00321	CcSEcCtD
Fexofenadine—Headache—Prednisone—Crohn's disease	0.000236	0.00319	CcSEcCtD
Fexofenadine—Nausea—Prednisone—Crohn's disease	0.000224	0.00303	CcSEcCtD
Fexofenadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	5.26e-05	0.0496	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transport of organic anions—ALB—Crohn's disease	5.02e-05	0.0474	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transport of organic anions—ALB—Crohn's disease	3.92e-05	0.037	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transport of organic anions—ALB—Crohn's disease	3.08e-05	0.0291	CbGpPWpGaD
Fexofenadine—SLCO1B3—Recycling of bile acids and salts—ALB—Crohn's disease	2.91e-05	0.0274	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transport of organic anions—ALB—Crohn's disease	2.64e-05	0.0249	CbGpPWpGaD
Fexofenadine—SLCO1A2—Recycling of bile acids and salts—ALB—Crohn's disease	2.28e-05	0.0215	CbGpPWpGaD
Fexofenadine—SLCO1B1—Recycling of bile acids and salts—ALB—Crohn's disease	1.95e-05	0.0184	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	1.86e-05	0.0176	CbGpPWpGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	1.78e-05	0.0168	CbGpPWpGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	1.78e-05	0.0168	CbGpPWpGaD
Fexofenadine—SLCO1B3—Bile acid and bile salt metabolism—ALB—Crohn's disease	1.52e-05	0.0143	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	1.46e-05	0.0137	CbGpPWpGaD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	1.39e-05	0.0131	CbGpPWpGaD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	1.39e-05	0.0131	CbGpPWpGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	1.26e-05	0.0119	CbGpPWpGaD
Fexofenadine—HRH1—G alpha (q) signalling events—MLN—Crohn's disease	1.24e-05	0.0117	CbGpPWpGaD
Fexofenadine—SLCO1A2—Bile acid and bile salt metabolism—ALB—Crohn's disease	1.19e-05	0.0113	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	1.18e-05	0.0112	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	1.14e-05	0.0108	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	1.11e-05	0.0105	CbGpPWpGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	1.11e-05	0.0105	CbGpPWpGaD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	1.09e-05	0.0103	CbGpPWpGaD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	1.09e-05	0.0103	CbGpPWpGaD
Fexofenadine—SLCO1B1—Bile acid and bile salt metabolism—ALB—Crohn's disease	1.02e-05	0.00963	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	1.01e-05	0.00957	CbGpPWpGaD
Fexofenadine—HRH1—IL-4 Signaling Pathway—SOCS1—Crohn's disease	1.01e-05	0.00956	CbGpPWpGaD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—GCKR—Crohn's disease	9.82e-06	0.00926	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	9.78e-06	0.00922	CbGpPWpGaD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	9.36e-06	0.00883	CbGpPWpGaD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	9.36e-06	0.00883	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	9.07e-06	0.00855	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	9.07e-06	0.00855	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	8.76e-06	0.00826	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	8.69e-06	0.0082	CbGpPWpGaD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	8.68e-06	0.00818	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	8.24e-06	0.00777	CbGpPWpGaD
Fexofenadine—HRH1—G alpha (q) signalling events—GPR65—Crohn's disease	8.02e-06	0.00756	CbGpPWpGaD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	7.71e-06	0.00727	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	7.45e-06	0.00702	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	7.17e-06	0.00676	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	7.08e-06	0.00668	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	7.08e-06	0.00668	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	6.88e-06	0.00649	CbGpPWpGaD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	6.82e-06	0.00643	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	6.67e-06	0.00629	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—ACKR2—Crohn's disease	6.62e-06	0.00624	CbGpPWpGaD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	6.6e-06	0.00622	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	6.56e-06	0.00618	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.39e-06	0.00603	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—MLN—Crohn's disease	6.27e-06	0.00592	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—IL17A—Crohn's disease	6.22e-06	0.00587	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	6.2e-06	0.00585	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	5.88e-06	0.00555	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.85e-06	0.00552	CbGpPWpGaD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	5.83e-06	0.0055	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.8e-06	0.00547	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—IL12B—Crohn's disease	5.78e-06	0.00546	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	5.71e-06	0.00539	CbGpPWpGaD
Fexofenadine—HRH1—IL-4 Signaling Pathway—TYK2—Crohn's disease	5.71e-06	0.00539	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.65e-06	0.00533	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	5.56e-06	0.00525	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	5.56e-06	0.00525	CbGpPWpGaD
Fexofenadine—HRH1—IL-4 Signaling Pathway—JAK2—Crohn's disease	5.45e-06	0.00514	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.43e-06	0.00512	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	5.31e-06	0.00501	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5e-06	0.00472	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.99e-06	0.0047	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.76e-06	0.00449	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.76e-06	0.00449	CbGpPWpGaD
Fexofenadine—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	4.7e-06	0.00443	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.56e-06	0.0043	CbGpPWpGaD
Fexofenadine—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	4.42e-06	0.00417	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	4.42e-06	0.00416	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.41e-06	0.00416	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—CCR9—Crohn's disease	4.35e-06	0.0041	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.27e-06	0.00403	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—IL10—Crohn's disease	4.23e-06	0.00399	CbGpPWpGaD
Fexofenadine—HRH1—G alpha (q) signalling events—RASGRP1—Crohn's disease	4.14e-06	0.00391	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—GPR65—Crohn's disease	4.04e-06	0.00381	CbGpPWpGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—ALB—Crohn's disease	4e-06	0.00377	CbGpPWpGaD
Fexofenadine—HRH1—IL-4 Signaling Pathway—STAT3—Crohn's disease	4e-06	0.00377	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.92e-06	0.0037	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PLA2G4F—Crohn's disease	3.9e-06	0.00368	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.9e-06	0.00368	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	3.89e-06	0.00367	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	3.78e-06	0.00357	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	3.77e-06	0.00356	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	3.71e-06	0.0035	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.65e-06	0.00344	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—MLN—Crohn's disease	3.55e-06	0.00334	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.46e-06	0.00327	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—ACKR2—Crohn's disease	3.4e-06	0.0032	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.35e-06	0.00316	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	3.33e-06	0.00314	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—MTMR3—Crohn's disease	3.32e-06	0.00313	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MLN—Crohn's disease	3.22e-06	0.00304	CbGpPWpGaD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—ALB—Crohn's disease	3.12e-06	0.00295	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PLA2G4F—Crohn's disease	3.06e-06	0.00289	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.96e-06	0.00279	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—CCR6—Crohn's disease	2.88e-06	0.00272	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	2.66e-06	0.0025	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PLA2G4F—Crohn's disease	2.62e-06	0.00247	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—MTMR3—Crohn's disease	2.61e-06	0.00246	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—FADS1—Crohn's disease	2.58e-06	0.00244	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—PTGER4—Crohn's disease	2.54e-06	0.00239	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—IFNG—Crohn's disease	2.49e-06	0.00235	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CCR9—Crohn's disease	2.46e-06	0.00232	CbGpPWpGaD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.45e-06	0.00232	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GPX4—Crohn's disease	2.42e-06	0.00228	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	2.38e-06	0.00225	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	2.38e-06	0.00225	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GCKR—Crohn's disease	2.34e-06	0.0022	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	2.31e-06	0.00218	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—GPR65—Crohn's disease	2.29e-06	0.00216	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CCR9—Crohn's disease	2.23e-06	0.00211	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—MTMR3—Crohn's disease	2.23e-06	0.0021	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—IL1B—Crohn's disease	2.22e-06	0.00209	CbGpPWpGaD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.1e-06	0.00198	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—GPR65—Crohn's disease	2.08e-06	0.00196	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.03e-06	0.00192	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—FADS1—Crohn's disease	2.03e-06	0.00191	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ACKR2—Crohn's disease	2.01e-06	0.00189	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MLN—Crohn's disease	1.9e-06	0.00179	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GPX4—Crohn's disease	1.9e-06	0.00179	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	1.89e-06	0.00178	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GCKR—Crohn's disease	1.84e-06	0.00173	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	1.8e-06	0.0017	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TAGAP—Crohn's disease	1.74e-06	0.00164	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—FADS1—Crohn's disease	1.74e-06	0.00164	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.68e-06	0.00158	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.67e-06	0.00157	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CCR6—Crohn's disease	1.63e-06	0.00154	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GPX4—Crohn's disease	1.63e-06	0.00153	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—TNF—Crohn's disease	1.61e-06	0.00152	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—ALB—Crohn's disease	1.59e-06	0.0015	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GCKR—Crohn's disease	1.57e-06	0.00148	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RSPO3—Crohn's disease	1.52e-06	0.00143	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.48e-06	0.0014	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CCR6—Crohn's disease	1.48e-06	0.00139	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.46e-06	0.00138	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SEL1L—Crohn's disease	1.44e-06	0.00136	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PTGER4—Crohn's disease	1.43e-06	0.00135	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCR9—Crohn's disease	1.32e-06	0.00124	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.31e-06	0.00124	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PLA2G4F—Crohn's disease	1.31e-06	0.00124	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PTGER4—Crohn's disease	1.3e-06	0.00123	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.25e-06	0.00118	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	1.24e-06	0.00117	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GPR65—Crohn's disease	1.23e-06	0.00116	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—IL3—Crohn's disease	1.22e-06	0.00115	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	1.22e-06	0.00115	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—RASGRP1—Crohn's disease	1.18e-06	0.00111	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	1.18e-06	0.00111	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.15e-06	0.00108	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.12e-06	0.00106	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MTMR3—Crohn's disease	1.12e-06	0.00105	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL3—Crohn's disease	1.11e-06	0.00105	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—RASGRP1—Crohn's disease	1.07e-06	0.00101	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.07e-06	0.00101	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MTMR3—Crohn's disease	1.05e-06	0.000991	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	9.81e-07	0.000926	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—CXCL8—Crohn's disease	9.28e-07	0.000876	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	9.25e-07	0.000872	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCR6—Crohn's disease	8.73e-07	0.000824	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—FADS1—Crohn's disease	8.69e-07	0.00082	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—IL2RA—Crohn's disease	8.55e-07	0.000807	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—FADS1—Crohn's disease	8.19e-07	0.000772	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GPX4—Crohn's disease	8.14e-07	0.000767	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	7.94e-07	0.000749	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RBX1—Crohn's disease	7.9e-07	0.000745	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GCKR—Crohn's disease	7.86e-07	0.000741	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL2RA—Crohn's disease	7.77e-07	0.000733	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTGER4—Crohn's disease	7.69e-07	0.000725	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GPX4—Crohn's disease	7.67e-07	0.000723	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ALB—Crohn's disease	7.44e-07	0.000701	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GCKR—Crohn's disease	7.41e-07	0.000698	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	6.93e-07	0.000653	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RIPK2—Crohn's disease	6.72e-07	0.000633	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL3—Crohn's disease	6.55e-07	0.000618	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTGS2—Crohn's disease	6.51e-07	0.000614	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	6.33e-07	0.000597	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ALB—Crohn's disease	5.84e-07	0.000551	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	5.75e-07	0.000542	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SOCS1—Crohn's disease	5.74e-07	0.000541	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—TYK2—Crohn's disease	5.47e-07	0.000516	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	5.34e-07	0.000504	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	5.25e-07	0.000495	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—JAK2—Crohn's disease	5.22e-07	0.000492	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTGS2—Crohn's disease	5.11e-07	0.000482	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ALB—Crohn's disease	5e-07	0.000471	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SMAD3—Crohn's disease	4.96e-07	0.000467	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	4.76e-07	0.000449	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL2RA—Crohn's disease	4.59e-07	0.000433	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTGS2—Crohn's disease	4.37e-07	0.000412	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TYK2—Crohn's disease	3.23e-07	0.000305	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—JAK2—Crohn's disease	3.08e-07	0.000291	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCL8—Crohn's disease	2.81e-07	0.000265	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6—Crohn's disease	2.68e-07	0.000252	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALB—Crohn's disease	2.5e-07	0.000236	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALB—Crohn's disease	2.36e-07	0.000222	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STAT3—Crohn's disease	2.26e-07	0.000213	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTGS2—Crohn's disease	2.19e-07	0.000206	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTGS2—Crohn's disease	2.06e-07	0.000194	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6—Crohn's disease	1.58e-07	0.000149	CbGpPWpGaD
